Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily E Holladay

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
ACR Open Rheumatology|May 8, 2026
Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness RegistryNicholas P McCormick, Cristiano S Moura, Jingyi Zhang, et al.
Arthritis Research & Therapy|April 12, 2024
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuationEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 11, 2025
Where we Live matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United StatesBrittany Banbury, Sharon Dowell, Christopher Jenkins, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 26, 2025
The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical OutcomesSharon Dowell, Brittany Banbury, Christopher Jenkins, et al.
Arthritis Care & Research|February 16, 2026
Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker DiagnosticsJeffrey R Curtis, Shanette Daigle, Emily E Holladay, et al.
RMD Open|January 27, 2026
Characteristics, treatments and outcomes of patients with dermatomyositis using real-world dataMichael George, Ellen Romich, Thomas R Riley, et al.
Arthritis Care & Research|May 8, 2024
Real-World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory TherapyEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2026
Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general-population cohort analysis with extended quantile g-computationNaizhuo Zhao, Sasha Bernatsky, Sharon Dowell, et al.
Arthritis Care & Research|September 26, 2023
COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice NetworkEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
ACR Open Rheumatology|May 8, 2026
Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness RegistryNicholas P McCormick, Cristiano S Moura, Jingyi Zhang, et al.
Arthritis Research & Therapy|April 12, 2024
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuationEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 11, 2025
Where we Live matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United StatesBrittany Banbury, Sharon Dowell, Christopher Jenkins, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 26, 2025
The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical OutcomesSharon Dowell, Brittany Banbury, Christopher Jenkins, et al.
Arthritis Care & Research|February 16, 2026
Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker DiagnosticsJeffrey R Curtis, Shanette Daigle, Emily E Holladay, et al.
RMD Open|January 27, 2026
Characteristics, treatments and outcomes of patients with dermatomyositis using real-world dataMichael George, Ellen Romich, Thomas R Riley, et al.
Arthritis Care & Research|May 8, 2024
Real-World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory TherapyEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2026
Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general-population cohort analysis with extended quantile g-computationNaizhuo Zhao, Sasha Bernatsky, Sharon Dowell, et al.
Arthritis Care & Research|September 26, 2023
COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice NetworkEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.
Pageof 1